Analysts at RBC Capital Reiterate their Buy rating for Healthsouth (HLS) with $55.0 TP; Laboratory America Holdings (LH) Shorts Increased By 19.46%

November 15, 2017 - By Darrin Black

Laboratory Corporation America Holdings (NYSE:LH) had an increase of 19.46% in short interest. LH’s SI was 2.76M shares in November as released by FINRA. Its up 19.46% from 2.31 million shares previously. With 814,700 avg volume, 3 days are for Laboratory Corporation America Holdings (NYSE:LH)’s short sellers to cover LH’s short positions. The stock increased 0.03% or $0.05 during the last trading session, reaching $149.91. About shares traded. Laboratory Corp. of America Holdings (NYSE:LH) has risen 10.51% since November 15, 2016 and is uptrending. It has underperformed by 6.19% the S&P500.

Among 14 analysts covering Healthsouth (NYSE:HLS), 7 have Buy rating, 1 Sell and 6 Hold. Therefore 50% are positive. Healthsouth has $56.0 highest and $40 lowest target. $47.67’s average target is -1.97% below currents $48.63 stock price. Healthsouth had 30 analyst reports since July 31, 2015 according to SRatingsIntel. As per Thursday, September 7, the company rating was maintained by KeyBanc Capital Markets. The firm has “Buy” rating given on Monday, October 9 by RBC Capital Markets. The stock of HealthSouth Corp (NYSE:HLS) earned “Outperform” rating by RBC Capital Markets on Monday, October 31. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, July 5. The stock of HealthSouth Corp (NYSE:HLS) has “Underweight” rating given on Monday, June 27 by Barclays Capital. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, July 31 report. Mizuho downgraded the shares of HLS in report on Wednesday, November 9 to “Neutral” rating. The stock of HealthSouth Corp (NYSE:HLS) has “Outperform” rating given on Monday, February 27 by RBC Capital Markets. Mizuho maintained the stock with “Buy” rating in Friday, April 29 report. The stock has “Buy” rating by Robert W. Baird on Friday, September 1.

Investors sentiment increased to 1.4 in 2017 Q2. Its up 0.05, from 1.35 in 2017Q1. It improved, as 21 investors sold HealthSouth Corp shares while 97 reduced holdings. 53 funds opened positions while 112 raised stakes. 85.97 million shares or 5.48% more from 81.51 million shares in 2017Q1 were reported. Invest Centers Of America invested 0.36% of its portfolio in HealthSouth Corp (NYSE:HLS). Amalgamated Financial Bank holds 0.02% in HealthSouth Corp (NYSE:HLS) or 12,847 shares. Regions Corporation invested in 0% or 8,365 shares. Lsv Asset reported 481,658 shares stake. Renaissance Limited Co reported 8,288 shares or 0.01% of all its holdings. Northwestern Mutual Wealth Management stated it has 0% in HealthSouth Corp (NYSE:HLS). Jefferies Gp Ltd Liability owns 29,152 shares. Trexquant Lp invested in 5,866 shares. Jpmorgan Chase Com holds 0.04% or 4.00 million shares in its portfolio. New York State Teachers Retirement invested in 21,500 shares. Brandywine Glob Investment Mgmt Limited Co accumulated 287,683 shares. Alliancebernstein Lp owns 187,744 shares. Morgan Stanley has 246,653 shares for 0% of their portfolio. Redwood Investments Limited Liability Corporation holds 229,826 shares or 1.12% of its portfolio. Moreover, Proshare Advsrs Llc has 0.01% invested in HealthSouth Corp (NYSE:HLS) for 16,047 shares.

Analysts await HealthSouth Corp (NYSE:HLS) to report earnings on February, 20. They expect $0.65 earnings per share, down 9.72% or $0.07 from last year’s $0.72 per share. HLS’s profit will be $63.89M for 18.70 P/E if the $0.65 EPS becomes a reality. After $0.66 actual earnings per share reported by HealthSouth Corp for the previous quarter, Wall Street now forecasts -1.52% negative EPS growth.

HealthSouth Corporation is a well-known provider of post-acute healthcare services, offering both facility and home post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company has market cap of $4.78 billion. The Firm manages its activities through divisions, including inpatient rehabilitation, and home health and hospice. It has a 17.74 P/E ratio. It is an owner and operator of inpatient rehabilitation hospitals.

The stock decreased 0.12% or $0.06 during the last trading session, reaching $48.63. About shares traded. HealthSouth Corp (NYSE:HLS) has risen 15.04% since November 15, 2016 and is uptrending. It has underperformed by 1.66% the S&P500.

Among 18 analysts covering Laboratory Corp (NYSE:LH), 9 have Buy rating, 0 Sell and 9 Hold. Therefore 50% are positive. Laboratory Corp had 43 analyst reports since July 29, 2015 according to SRatingsIntel. On Monday, October 16 the stock rating was maintained by Piper Jaffray with “Buy”. Zacks downgraded the stock to “Buy” rating in Monday, August 17 report. The company was maintained on Friday, June 9 by Jefferies. Citigroup initiated Laboratory Corp. of America Holdings (NYSE:LH) on Friday, September 9 with “Neutral” rating. The rating was maintained by Robert W. Baird on Sunday, October 15 with “Hold”. The stock of Laboratory Corp. of America Holdings (NYSE:LH) earned “Buy” rating by Canaccord Genuity on Tuesday, April 26. The stock of Laboratory Corp. of America Holdings (NYSE:LH) earned “Hold” rating by Jefferies on Tuesday, September 12. The stock has “Buy” rating by Canaccord Genuity on Monday, September 11. Mizuho maintained it with “Neutral” rating and $139 target in Friday, February 17 report. As per Thursday, July 27, the company rating was maintained by Craig Hallum.

Since May 22, 2017, it had 0 insider buys, and 1 insider sale for $505,259 activity. BERBERIAN LANCE had sold 3,613 shares worth $505,259 on Monday, May 22.

Investors sentiment increased to 1.06 in 2017 Q2. Its up 0.05, from 1.01 in 2017Q1. It is positive, as 44 investors sold Laboratory Corp. of America Holdings shares while 207 reduced holdings. 66 funds opened positions while 199 raised stakes. 93.49 million shares or 2.05% more from 91.61 million shares in 2017Q1 were reported. Mitsubishi Ufj And reported 0.07% stake. Manchester Capital Mngmt Lc, Vermont-based fund reported 6,001 shares. Renaissance Lc reported 506,405 shares. Captrust Financial Advsrs owns 50 shares or 0% of their US portfolio. 1,969 are held by Putnam Invests Lc. Alphamark Advisors Ltd Company has 15 shares. Oppenheimer Company holds 0.01% or 2,631 shares. Pura Vida Invs Ltd invested in 3.98% or 65,000 shares. Amica Retiree Medical Trust holds 0.08% in Laboratory Corp. of America Holdings (NYSE:LH) or 608 shares. Hm Payson & Commerce invested 0.02% in Laboratory Corp. of America Holdings (NYSE:LH). Somerville Kurt F invested 0.12% of its portfolio in Laboratory Corp. of America Holdings (NYSE:LH). Tokio Marine Asset Mngmt Company holds 0.03% of its portfolio in Laboratory Corp. of America Holdings (NYSE:LH) for 1,378 shares. Cwm Ltd Llc holds 0% of its portfolio in Laboratory Corp. of America Holdings (NYSE:LH) for 237 shares. Dixon Hubard Feinour Brown Inc Va has invested 1.69% in Laboratory Corp. of America Holdings (NYSE:LH). Amer Bankshares holds 1.77% or 35,855 shares in its portfolio.

Laboratory Corporation of America Holdings is a life sciences firm that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The company has market cap of $15.36 billion. The Firm operates as a healthcare diagnostics company. It has a 20.92 P/E ratio. The Firm operates through two divisions: LabCorp Diagnostics and Covance Drug Development (CDD).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>